COMMUNIQUÉS West-GlobeNewswire

NGX Bio Raises $3 Million to Fund Growth of Its DNA Sequencing Marketplace
15/08/2017
SAN FRANCISCO, Aug. 15, 2017 (GLOBE NEWSWIRE) -- NGX Bio, Inc., ( www.NGXbio.com ) the premier marketplace for online DNA sequencing services, announced it has closed a $3 million funding round. The round was led by 180 [...]
Overallotment option of 15% has been exercised
15/08/2017
Company announcement - No. 37/2017 Overallotment option of 15% has been exercised The 15% overallotment option in connection with Zealand Pharma A/S' initial public offering of American Depositary Shares on the Nasdaq [...]
End of stabilization period
15/08/2017
Company announcement - No. 36/2017 End of stabilization period Zealand Pharma A/S has today received notification regarding the end of the stabilization period Copenhagen, August 15, 2017 - With reference to company [...]
Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension
15/08/2017
MOUNTAIN VIEW, Calif., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces that the [...]
Bolton NHS Foundation Trust selects Allscripts to enhance care and clinical engagement
15/08/2017
U.K. Trust launches Allscripts Sunrise(TM) EPR to enable integrated patient record BOLTON, United Kingdom, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Bolton NHS Foundation Trust has selected Allscripts Sunrise Electronic Patient [...]
Curetis Partners with Biotest to support academic PEPPER Pentaglobin® Peritonitis Trial with Unyvero IAI Application
15/08/2017
Curetis Partners with Biotest to support academic PEPPER Pentaglobin ® Peritonitis Trial with Unyvero IAI Application - Trial sponsored by University Clinic RWTH Aachen investigates personalized treatment approaches [...]
Changes in Novo Nordisk Executive Management
15/08/2017
Bagsværd, Denmark, 15 August 2017 - Novo Nordisk A/S today announced two changes to its Executive Management team. As of 1 October, Camilla Sylvest, senior vice president in charge of Novo Nordisk's operations in Region [...]
Immunicum AB (publ) Announces Last Patient Last Visit in the Ongoing Phase I/II Hepatocellular Carcinoma Study
15/08/2017
Press Release 15 August 2017 Immunicum AB (publ) Announces Last Patient Last Visit in the Ongoing Phase I/II Hepatocellular Carcinoma Study Immunicum AB (publ; First North Premier: IMMU.ST), a biopharmaceutical company [...]
Shire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe
15/08/2017
Shire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe Lifitegrast, if approved, would be the first and only new class treatment to address the signs and [...]
Nicox annonce une levée de fonds de €26,250 millions
15/08/2017
Communiqué de Presse Nicox annonce une levée de fonds de €26,25 millions 15 août 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX, éligible PEA-PME), société internationale spécialisée en [...]
Nicox announces €26.25 million financing
15/08/2017
Press Release Nicox announces €26.25 million financing August 15, 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic company, today announced a reserved capital [...]
Taconic Biosciences annonce un partenariat avec Cergentis B.V. pour fournir des services de mappage transgénique
15/08/2017
HUDSON, New York, le 14 août 2017 (GLOBE NEWSWIRE) - Taconic Biosciences, leader mondial en matière de modèles de souris génétiquement modifiés et de services associés, a annoncé qu'elle a signé un accord de [...]
Ossur Hf : Össur hf. initiates a new share buyback program
14/08/2017
Announcement from Össur hf. No. 59/2017 Reykjavík, 14 August 2017 Össur hf. has decided to initiate a new share buyback program (the "Program") tomorrow, 15 August 2017, which will replace the share buyback program that [...]
Ossur Hf : Share buyback program completed
14/08/2017
Announcement from Össur hf. No. 58/2017 Reykjavík, 14 August 2017 On 1 December 2016, Össur hf. initiated a share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program was to [...]
Crown Bioscience annonce les résultats du deuxième trimestre et nomme le Dr Yangzhou Wang en qualité de Vice Président senior de Global Operations
14/08/2017
SANTA CLARA, Californie, le 14 août 2017 (GLOBE NEWSWIRE) - Crown Bioscience , filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services de [...]
Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology
14/08/2017
First-of-its-Kind Randomized Clinical Trial Will Evaluate One-Month DAPT in Patients Following PCI Procedures with the Newer-Generation Durable Polymer Resolute Onyx DES DUBLIN- August 14, 2017 - Medtronic plc (NYSE: [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 11 August 2017
14/08/2017
Bagsværd, Denmark, 14 August 2017 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
Taconic Biosciences Announces Partnership With Cergentis B.V. to Provide Transgene Mapping Services
14/08/2017
HUDSON, N.Y., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement with Cergentis B.V [...]
Novo Nordisk A/S - Share repurchase programme
14/08/2017
Bagsværd, Denmark, 14 Aug 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Pages